Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults. In an ...
YPrime Releases Reimagined eCOA Automated Data Change Form for More Efficient Clinical Trial Data Management
A 2024 survey of eCOA professionals at sponsor organizations revealed that 50% of respondents identified eCOA Data Change ...